These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 28124996)

  • 41. Tumor microenvironment in invasive lobular carcinoma: possible therapeutic targets.
    Nakagawa S; Miki Y; Miyashita M; Hata S; Takahashi Y; Rai Y; Sagara Y; Ohi Y; Hirakawa H; Tamaki K; Ishida T; Watanabe M; Suzuki T; Ohuchi N; Sasano H
    Breast Cancer Res Treat; 2016 Jan; 155(1):65-75. PubMed ID: 26715212
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The myoepithelial cell layer may serve as a potential trigger factor for different outcomes of stage-matched invasive lobular and ductal breast cancers.
    Hsiao YH; Tsai HD; Chou MC; Man YG
    Int J Biol Sci; 2011 Feb; 7(2):147-53. PubMed ID: 21326853
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The sensitivity of pre-operative axillary staging in breast cancer: comparison of invasive lobular and ductal carcinoma.
    Topps A; Clay V; Absar M; Howe M; Lim Y; Johnson R; Bundred N
    Eur J Surg Oncol; 2014 Jul; 40(7):813-7. PubMed ID: 24797703
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ultrasonographic findings of invasive lobular carcinoma differentiation of invasive lobular carcinoma from invasive ductal carcinoma by ultrasonography.
    Ohta T; Tsujimoto F; Nakajima Y; Fukuda M; Takag M
    Breast Cancer; 2005; 12(4):304-11. PubMed ID: 16286911
    [TBL] [Abstract][Full Text] [Related]  

  • 45. An Analysis of Oncotype DX Recurrence Scores and Clinicopathologic Characteristics in Invasive Lobular Breast Cancer.
    Felts JL; Zhu J; Han B; Smith SJ; Truica CI
    Breast J; 2017 Nov; 23(6):677-686. PubMed ID: 28097781
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical-pathologic features, long term-outcome and surgical treatment in a large series of patients with invasive lobular carcinoma (ILC) and invasive ductal carcinoma (IDC).
    Biglia N; Maggiorotto F; Liberale V; Bounous VE; Sgro LG; Pecchio S; D'Alonzo M; Ponzone R
    Eur J Surg Oncol; 2013 May; 39(5):455-60. PubMed ID: 23490334
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Preoperative MRT of the breast in invasive lobular carcinoma in comparison with invasive ductal carcinoma].
    Diekmann F; Diekmann S; Beljavskaja M; Bick U; Taupitz M; Blohmer JU; Winzer KJ; Hamm B
    Rofo; 2004 Apr; 176(4):544-9. PubMed ID: 15088179
    [TBL] [Abstract][Full Text] [Related]  

  • 48. CAR expression in invasive breast carcinoma and its effect on adenovirus transduction efficiency.
    Phung AT; Shah JR; Dong T; Reid T; Larson C; Sanchez AB; Oronsky B; Trogler WC; Kummel AC; Aisagbonhi O; Blair SL
    Breast Cancer Res; 2024 Sep; 26(1):131. PubMed ID: 39256827
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Is invasive lobular carcinoma different from invasive ductal carcinoma?
    Mersin H; Yildirim E; Gülben K; Berberoğlu U
    Eur J Surg Oncol; 2003 May; 29(4):390-5. PubMed ID: 12711296
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer.
    Ciriello G; Gatza ML; Beck AH; Wilkerson MD; Rhie SK; Pastore A; Zhang H; McLellan M; Yau C; Kandoth C; Bowlby R; Shen H; Hayat S; Fieldhouse R; Lester SC; Tse GM; Factor RE; Collins LC; Allison KH; Chen YY; Jensen K; Johnson NB; Oesterreich S; Mills GB; Cherniack AD; Robertson G; Benz C; Sander C; Laird PW; Hoadley KA; King TA; ; Perou CM
    Cell; 2015 Oct; 163(2):506-19. PubMed ID: 26451490
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Influence of semi-quantitative oestrogen receptor expression on adjuvant endocrine therapy efficacy in ductal and lobular breast cancer - a TEAM study analysis.
    van de Water W; Fontein DB; van Nes JG; Bartlett JM; Hille ET; Putter H; Robson T; Liefers GJ; Roumen RM; Seynaeve C; Dirix LY; Paridaens R; Kranenbarg EM; Nortier JW; van de Velde CJ
    Eur J Cancer; 2013 Jan; 49(2):297-304. PubMed ID: 22954666
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Survival analysis between patients with invasive ductal and invasive lobular breast cancer.
    Dian D; Herold H; Mylonas I; Scholz C; Janni W; Sommer H; Friese K
    Arch Gynecol Obstet; 2009 Jan; 279(1):23-8. PubMed ID: 18449551
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Invasive lobular carcinoma of the breast: local recurrence after breast-conserving therapy by subtype approximation and surgical margin.
    Braunstein LZ; Brock JE; Chen YH; Truong L; Russo AL; Arvold ND; Harris JR
    Breast Cancer Res Treat; 2015 Jan; 149(2):555-64. PubMed ID: 25604797
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Invasive lobular vs. ductal breast cancer: a stage-matched comparison of outcomes.
    Wasif N; Maggard MA; Ko CY; Giuliano AE
    Ann Surg Oncol; 2010 Jul; 17(7):1862-9. PubMed ID: 20162457
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Accuracy of conservative treatment for infiltrating lobular breast cancer: a retrospective study of 217 infiltrating lobular carcinomas and 2155 infiltrating ductal carcinomas].
    Paumier A; Sagan C; Campion L; Fiche M; Andrieux N; Dravet F; Pioud R; Classe JM
    J Gynecol Obstet Biol Reprod (Paris); 2003 Oct; 32(6):529-34. PubMed ID: 14593298
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Patients with invasive lobular breast cancer are less likely to undergo breast-conserving surgery: a population based study in the Netherlands.
    Truin W; Roumen RM; Siesling S; van der Heiden-van der Loo M; Duijm LE; Tjan-Heijnen VC; Voogd AC
    Ann Surg Oncol; 2015 May; 22(5):1471-8. PubMed ID: 25323475
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immunological subtypes in breast cancer are prognostic for invasive ductal but not for invasive lobular breast carcinoma.
    Engels CC; Fontein DB; Kuppen PJ; de Kruijf EM; Smit VT; Nortier JW; Liefers GJ; van de Velde CJ; Bastiaannet E
    Br J Cancer; 2014 Jul; 111(3):532-8. PubMed ID: 24937677
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clonal profiling of mixed lobular and ductal carcinoma revealed by multiplex ligation-dependent probe amplification and fluorescence in situ hybridization.
    Tajiri R; Inokuchi M; Sawada-Kitamura S; Kawashima H; Nakamura R; Oyama T; Dobashi Y; Ooi A
    Pathol Int; 2014 May; 64(5):231-6. PubMed ID: 24888777
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Imaging features and conspicuity of invasive lobular carcinomas on digital breast tomosynthesis.
    Chamming's F; Kao E; Aldis A; Ferré R; Omeroglu A; Reinhold C; Mesurolle B
    Br J Radiol; 2017 May; 90(1073):20170128. PubMed ID: 28368663
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Invasive lobular and invasive ductal carcinoma of the breast show distinct patterns of vascular endothelial growth factor expression and angiogenesis.
    Lee AH; Dublin EA; Bobrow LG; Poulsom R
    J Pathol; 1998 Aug; 185(4):394-401. PubMed ID: 9828838
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.